| Compound Information | SONAR Target prediction | | Name: | 2-(4,4-dimethylcyclohexyl)propan-2-ol | | Unique Identifier: | NRB 02318 | | MolClass: | Checkout models in ver1.5 and ver1.0 | | Molecular Formula: | C11H22O | | Molecular Weight: | 148.117 g/mol | | X log p: | -0.528 (online calculus) | | Lipinksi Failures | 0 | | TPSA | 0 | | Hydrogen Bond Donor Count: | 0 | | Hydrogen Bond Acceptors Count: | 1 | | Rotatable Bond Count: | 1 | | Canonical Smiles: | CC(C)(O)C1CCC(C)(C)CC1 | | Generic_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | | Chemical_iupac_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | | Drug_type: | Experimental | | Drugbank_id: | EXPT00530 | | Logp: | 3.73 | | Drug_category: | Sex Hormone-Binding Globulin inhibitor | | Organisms_affected: | -1 |
| Species: |
4932 |
| Condition: |
SWE1 |
| Replicates: |
2 |
| Raw OD Value: r im |
0.6354±0.00643467 |
| Normalized OD Score: sc h |
0.8382±0.0241815 |
| Z-Score: |
-9.8086±1.09272 |
| p-Value: |
8.13258e-20 |
| Z-Factor: |
0.230419 |
| Fitness Defect: |
43.9558 |
| Bioactivity Statement: |
Active |
| Experimental Conditions | | | Library: | Maybridge1000 | | Plate Number and Position: | 8|A8 | | Drug Concentration: | 50.00 nM | | OD Absorbance: | 600 nm | | Robot Temperature: | 21.40 Celcius | | Date: | 2007-08-22 YYYY-MM-DD | | Plate CH Control (+): | 0.03955±0.00272 | | Plate DMSO Control (-): | 0.74005±0.01428 | | Plate Z-Factor: | 0.9201 |
|  png
ps
pdf |
| 15981575 |
(2S,3R,7R)-3,7-dimethyltridecan-2-ol |
| 16049918 |
(1S,4R)-5-deuterio-6-hydroxy-bicyclo[2.2.1]heptane |
| 16055632 |
(3S,4S,5S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-ethyl-6-methyl-heptan-2-yl]-4,10,13-trimethyl-2,3,4,5,6,7
,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
| 16057425 |
[(1R,4R,5R)-1,7,7-trimethyl-5-bicyclo[2.2.1]heptyl]methanol |
| 16057429 |
(1R,3S,4S)-6,6-dimethylbicyclo[2.2.1]heptan-3-ol |
| 16057431 |
magnesium; decan-1-olate; propan-2-olate |
| active | Cluster 1300 | Additional Members: 1 | Rows returned: 0 | |
|
